• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四氢呋喃木脂素及其类似物作为特异性血小板活化因子拮抗剂的构象与活性

Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists.

作者信息

Biftu T, Gamble N F, Doebber T, Hwang S B, Shen T Y, Snyder J, Springer J P, Stevenson R

出版信息

J Med Chem. 1986 Oct;29(10):1917-21. doi: 10.1021/jm00160a020.

DOI:10.1021/jm00160a020
PMID:3020247
Abstract

The six (racemic or meso) isomers of 3,4-dimethyl-2,5-bis(3,4-dimethoxyphenyl)tetrahydrofuran and four corresponding desmethyl analogues were prepared and assayed as inhibitors of platelet activating factor (PAF) receptor binding to rabbit platelet plasma membranes. The inhibition by these isomers is stereodependent and varies with the gross shape of the molecules as determined by the molecular mechanics program MM2. The most potent PAF antagonist in this group of compounds is trans-2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-652,731, 14) with an IC50 of 0.02 microM.

摘要

制备了3,4-二甲基-2,5-双(3,4-二甲氧基苯基)四氢呋喃的六种(外消旋或内消旋)异构体和四种相应的去甲基类似物,并作为血小板活化因子(PAF)受体与兔血小板质膜结合的抑制剂进行了测定。这些异构体的抑制作用具有立体依赖性,并且根据分子力学程序MM2确定的分子总体形状而有所不同。该组化合物中最有效的PAF拮抗剂是反式-2,5-双(3,4,5-三甲氧基苯基)四氢呋喃(L-652,731, 14),IC50为0.02微摩尔。

相似文献

1
Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists.四氢呋喃木脂素及其类似物作为特异性血小板活化因子拮抗剂的构象与活性
J Med Chem. 1986 Oct;29(10):1917-21. doi: 10.1021/jm00160a020.
2
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.反式-2,5-双-(3,4,5-三甲氧基苯基)四氢呋喃。一种口服活性的血小板活化因子特异性竞争性受体拮抗剂。
J Biol Chem. 1985 Dec 15;260(29):15639-45.
3
Species difference in the specific receptors of platelet activating factor.血小板活化因子特异性受体的种属差异。
Biochem Pharmacol. 1986 Dec 15;35(24):4511-8. doi: 10.1016/0006-2952(86)90772-0.
4
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
J Lipid Mediat. 1992 Feb;5(1):23-40.
5
Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii.木兰脂素A和B,从凹叶厚朴花芽中提取的新型抗血小板活化因子四氢呋喃木脂素。
J Nat Prod. 1998 Jun 26;61(6):808-11. doi: 10.1021/np970445+.
6
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.强效口服活性血小板活化因子(PAF)拮抗剂(-)-反式-(2S,5S)-2-[3-[(2-氧代丙基)磺酰基]-4-正丙氧基-5-(3-羟基丙氧基)-苯基]-5-(3,4,5-三甲氧基苯基)四氢呋喃及其水溶性前药磷酸酯的开发、合成与生物学评价
J Med Chem. 1992 Sep 18;35(19):3474-82. doi: 10.1021/jm00097a005.
7
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.L-659,989的生化与药理学特性:一种血小板活化因子的超强效、选择性及竞争性受体拮抗剂
J Pharmacol Exp Ther. 1988 Aug;246(2):534-41.
8
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.(±)-反式-2-(3-甲氧基-5-甲基磺酰基-4-丙氧基苯基)-5-(3,4,5-三甲氧基苯基)四氢呋喃(L-659,989),一种新型强效血小板活化因子受体拮抗剂。
Biochem Biophys Res Commun. 1988 Feb 15;150(3):1213-20. doi: 10.1016/0006-291x(88)90758-9.
9
Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.血小板活化因子(PAF)受体拮抗剂反式-2,5-(3,4,5-三甲氧基苯基)四氢呋喃(L-652,731)对大鼠体内PAF诱导反应的抑制作用
J Pharmacol Exp Ther. 1986 Dec;239(3):841-5.
10
Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.表木栓醇的药理学特性:一种具有血小板活化因子拮抗剂活性的呋喃呋喃木脂素。
J Lipid Mediat. 1993 May;7(1):1-9.

引用本文的文献

1
Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.血小板活化因子(PAF)刺激中性粒细胞中PAF合成酶乙酰辅酶A:1-烷基-sn-甘油-3-磷酸胆碱O2-乙酰基转移酶以及PAF的合成。
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7557-61. doi: 10.1073/pnas.84.21.7557.